Data / Form D filings / SELKIRK PHARMA, INC.
SELKIRK PHARMA, INC.: Form D filings
SELKIRK PHARMA, INC., a manufacturing company in Spokane, WA, filed 5 Form D notices with the SEC between 2018 and 2023. The latest, on September 13, 2023, reports $24.1 million sold of a $25 million offering to 114 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 9110 W GRANITE AVE, Spokane, WA, 99224
- Phone
- (509) 340-9909
- Industry
- Manufacturing
- Entity type
- Corporation
- Incorporated in
- Washington
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1732446
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 13, 2023 | New notice | $25,000,002 | $24,102,603 | $897,399 | 114 | Aug 25, 2023 | sec.gov |
| Dec 30, 2021 | New notice | $35,000,005 | $35,000,005 | 137 | Dec 15, 2021 | sec.gov | |
| Sep 15, 2020 | New notice | $15,000,000 | $12,174,000 | $2,826,000 | 79 | Aug 31, 2020 | sec.gov |
| Feb 25, 2020 | New notice | $18,000,000 | $9,051,286 | $8,948,714 | 65 | Feb 7, 2020 | sec.gov |
| Mar 2, 2018 | New notice | $5,000,000 | $1,725,000 | $3,275,000 | 19 | Feb 16, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| PATRICK HAFFEY | Executive Officer, Director | |
| JOE HERZOG | Executive Officer, Director | |
| MARSHALL CREW | Director | |
| TOM TOBIN | Director | |
| ROD RAABE | Director |
Other manufacturing companies in Washington that filed recently
- Mercer MotorWorks, Inc. $155,000 · Oct 15, 2026
- BEDSON DRUM CO. offering · Sep 1, 2026
Every Form D from the week of Sep 11, 2023 · All recent filings in Washington · All recent Manufacturing filings
Read from SEC EDGAR. Amount sold is what SELKIRK PHARMA, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.